-Veterinary pharmaceutical development of conventional and non-conventional dosage forms, including preformulation studies using differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FTIR), in vitro assays and in vivo studies to determine the effectiveness and efficiency of the product developed.-Development of analytical methods by HPLC for release studies in the USP apparatus IV (Flow-through-Cell), fluorescence spectrometry to determine the antimicrobial activity, and immunoassays (ELISA) with the purpose to quantify immunoglobulin A, superoxide dismutase, C-Reactive protein, and heat shock proteins (HSP60 and HSP70).

-Evaluation of viable alternatives to the use of antibiotics in models of prevention and treatment of pathogen infections in broiler chickens, as well as in "in ovo" models.-Preparation of solid dispersions and nanocapsules to increase the solubility of poorly water-soluble drugs of importance in the poultry industry.

Development and optimization of modified release microparticles through fluidized bed coating processes, as well as their release studies in the USP apparatus IV (Flow-through-Cell).

–Review of dossiers for registration of pharmaceutical products and medicated premixes, as well as the authorization of feed premixes containing different additives for veterinary use.–Training of SAGARPA-SENASICA staff to improve the evaluation criteria of dossiers through refresher courses to apply the current international regulations.

-Evaluation of viable alternatives to the use of antibiotics in models of prevention and treatment of pathogen infections and necrotic enteritis in broiler chickens.-Development of spectrophotometric methods for the quantification of enzymes produced by different Lactobacillus.

–Development and optimization of cell culture models to perform toxicity and permeability assays in formulations based on biopolymeric micro and nanoparticles, as well as the elaboration of the corresponding protocols.–The manager involved in the purchase decisions of materials, equipment, and kits for performing toxicity and permeability tests.

Development, optimization, and comparison of fluorometric methods with conventional methods to determine the antimicrobial activity of viable alternatives as a replacement to antibiotics against Gram negative and positive bacteria.

–Review of dossiers for registration of chemical and pharmaceutical products for veterinary use.–Training of SAGARPA-SENASICA staff to improve the evaluation criteria of dossiers through refresher courses to apply the current national and international regulation.–Encourage the updating of national regulation for the registration of veterinary products through its harmonization with international regulation.–Consulting to SAGARPA-SENASICA staff about the importance of presenting stability studies of pharmaceutical products and analytical methods.

–Development and characterization of biopolymeric nanocapsules to increase the solubility, stability, and permeability of phytopharmaceuticals, as well as to control their release.–Development and validation of analytical methods by HPLC, UV-vis spectrophotometry and infrared (IR) spectroscopy.

–Supervise research work student in the laboratory of pharmaceutical technology (bachelor's degree).–Support for the qualification of laboratory assignments such as quizzes, tests, and reports.–Advice for the correct use of laboratory equipment.

-Development and validation of analytical methods by standard addition for dissolution studies in the USP apparatus II and IV of dissolution.-Mechanistic analysis of drug release from tablets and multivariate analysis (principal component analysis, PCA) to compare dissolution profiles.

– Toxicological evaluation and permeability assays in cell cultures. – Ex vivo assays to determine the intestinal absorption of phytopharmaceuticals.– Release studies of nanocapsular systems using the USP apparatus IV with a dialysis adapter.